NFKB1 and type 2 diabetes mellitus: Overall, the present findings demonstrated that si-SNHG16 attenuates the high glucose-induced inflammatory response in diabetes through the miR-212-3p/NF-κB axis and SNHG16 can be used as a novel biomarker for patients with type 2 diabetes.